| Dr Jackie Werner, MD | |
|
2790 Clay Edwards Dr Ste 530, North Kansas City, MO 64116-3266 | |
| (816) 452-3300 | |
| (816) 453-0677 |
| Full Name | Dr Jackie Werner |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 8 Years |
| Location | 2790 Clay Edwards Dr Ste 530, North Kansas City, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558712430 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 94-09007 (Kansas) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 2020032940 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Kansas City Hospital | North kansas city, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Meritas Health Corporation | 6305748153 | 365 |
News Archive
The University of Illinois Medical Center at Chicago is the first academic medical center in the country to introduce a new "no stress" diagnostic system for assessing patients with heart failure and optimizing their treatment.
Health Secretary John Reid has set out plans to ensure patients across the country have equal access to treatments recommended by the independent National Institute for Clinical Excellence (NICE).
A new study posted to the bioRxiv preprint server focuses on a novel formulation of magnetization or saturation transfer. This method is developed by amalgamating theoretical and computational approaches based on a Bayesian deconvolution algorithm, which helps obtain data more accurately and determine the ligand-protein interaction.
Celsion Corporation, a biotechnology drug development company, today announced financial results for the second quarter and six months ended June 30, 2010 and addressed the progression of the clinical trials of ThermoDox, Celsion's heat activated liposomal encapsulation of doxorubicin. ThermoDox is currently being evaluated in the Phase III HEAT trial for the treatment of hepatocellular carcinoma and in a Phase I/II trial for patients with recurrent chest wall breast cancer.
Nearly 9 in 10 U.S. adults are "very" (55%) or "somewhat" (33%) concerned that the pharmaceutical industry will leverage the COVID-19 pandemic to raise drug prices.
› Verified 2 days ago
| Entity Name | Meritas Health Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801875091 PECOS PAC ID: 6305748153 Enrollment ID: O20040122001058 |
News Archive
The University of Illinois Medical Center at Chicago is the first academic medical center in the country to introduce a new "no stress" diagnostic system for assessing patients with heart failure and optimizing their treatment.
Health Secretary John Reid has set out plans to ensure patients across the country have equal access to treatments recommended by the independent National Institute for Clinical Excellence (NICE).
A new study posted to the bioRxiv preprint server focuses on a novel formulation of magnetization or saturation transfer. This method is developed by amalgamating theoretical and computational approaches based on a Bayesian deconvolution algorithm, which helps obtain data more accurately and determine the ligand-protein interaction.
Celsion Corporation, a biotechnology drug development company, today announced financial results for the second quarter and six months ended June 30, 2010 and addressed the progression of the clinical trials of ThermoDox, Celsion's heat activated liposomal encapsulation of doxorubicin. ThermoDox is currently being evaluated in the Phase III HEAT trial for the treatment of hepatocellular carcinoma and in a Phase I/II trial for patients with recurrent chest wall breast cancer.
Nearly 9 in 10 U.S. adults are "very" (55%) or "somewhat" (33%) concerned that the pharmaceutical industry will leverage the COVID-19 pandemic to raise drug prices.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jackie Werner, MD 2790 Clay Edwards Dr Ste 530, North Kansas City, MO 64116-3266 Ph: (816) 452-3300 | Dr Jackie Werner, MD 2790 Clay Edwards Dr Ste 530, North Kansas City, MO 64116-3266 Ph: (816) 452-3300 |
News Archive
The University of Illinois Medical Center at Chicago is the first academic medical center in the country to introduce a new "no stress" diagnostic system for assessing patients with heart failure and optimizing their treatment.
Health Secretary John Reid has set out plans to ensure patients across the country have equal access to treatments recommended by the independent National Institute for Clinical Excellence (NICE).
A new study posted to the bioRxiv preprint server focuses on a novel formulation of magnetization or saturation transfer. This method is developed by amalgamating theoretical and computational approaches based on a Bayesian deconvolution algorithm, which helps obtain data more accurately and determine the ligand-protein interaction.
Celsion Corporation, a biotechnology drug development company, today announced financial results for the second quarter and six months ended June 30, 2010 and addressed the progression of the clinical trials of ThermoDox, Celsion's heat activated liposomal encapsulation of doxorubicin. ThermoDox is currently being evaluated in the Phase III HEAT trial for the treatment of hepatocellular carcinoma and in a Phase I/II trial for patients with recurrent chest wall breast cancer.
Nearly 9 in 10 U.S. adults are "very" (55%) or "somewhat" (33%) concerned that the pharmaceutical industry will leverage the COVID-19 pandemic to raise drug prices.
› Verified 2 days ago
Dr. Bridget Alison Crowley, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2790 Clay Edwards Dr Ste 530, North Kansas City, MO 64116 Phone: 816-452-3300 Fax: 816-453-0677 | |
Raschelle Leanne Schowengerdt, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2790 Clay Edwards Dr Ste 1200, North Kansas City, MO 64116 Phone: 816-468-7800 Fax: 816-468-8531 | |
William K Seifert, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2790 Clay Edwards Drive, Suite 530, North Kansas City, MO 64116 Phone: 816-452-3300 Fax: 816-453-0677 | |
Amanda Humiston, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2790 Clay Edwards Dr, Suite 1200, North Kansas City, MO 64116 Phone: 816-468-7800 Fax: 816-468-8531 | |
Ronald D Fitch, D.O. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2790 Clay Edwards Dr, Suite 1200, North Kansas City, MO 64116 Phone: 816-468-7800 Fax: 816-468-8531 | |
Dr. Beena Green, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2790 Clay Edwards Dr Ste 1200, North Kansas City, MO 64116 Phone: 816-468-7800 Fax: 816-468-8531 | |
Dr. Michelle S. Daniels, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2790 Clay Edwards Drive, Suite 530, North Kansas City, MO 64116 Phone: 816-452-3300 Fax: 816-453-0677 |